Abstract
Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Adolescent Psychiatry
Title: Albert Ellis Rational-Emotive Behavior Therapy
Volume: 1 Issue: 1
Author(s): Richard Rosner
Affiliation:
Keywords: Rational emotive behavioral therapy, Albert Ellis, children and adolescents, review, neurotic behaviors, maladaptive, supportive therapy, psychoanalytically-oriented therapy, Alzheimer's disease
Abstract: Rational emotive behavioral therapy (REBT) is a form of cognitive behavioral therapy developed by Albert Ellis. Developed in the 1950s, REBT was one of the earliest forms of what became known as cognitive behavioral therapy. It was successfully adapted for children and adolescents in the 1980s (Barnard & Joyce, 1984) and has been studied extensively and shown to be effective in this population (Gonzales, Nelson, & Gutkin, 2004). This article provides a selective review of the literature, and brief overview of REBT, and discusses its advantages and disadvantages.
Export Options
About this article
Cite this article as:
Rosner Richard, Albert Ellis Rational-Emotive Behavior Therapy, Adolescent Psychiatry 2011; 1 (1) . https://dx.doi.org/10.2174/2210676611101010082
DOI https://dx.doi.org/10.2174/2210676611101010082 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>In Silico</i> Structural and Functional Analysis of <i>Bacillus</i> Uricases
Current Proteomics Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design Exploring and Exploiting Microbial Diversity through Metagenomics for Natural Product Drug Discovery
Current Topics in Medicinal Chemistry Interferon-Beta Therapy Monitoring in Multiple Sclerosis Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Immune Aging and Autoimmune Diseases in Children
Current Immunology Reviews (Discontinued) Phosphonomethoxyalkyl Analogs of Nucleotides
Current Pharmaceutical Design ABC Transporters in Extrahepatic Tissues: Pharmacological Regulation in Heart and Intestine
Current Medicinal Chemistry Multi-Modality Discrimination of Brain Glioma Grades Using Diffusion Tensor and Spectroscopic MRI
Recent Patents on Medical Imaging Current Treatment and Drug Discovery Against Leishmania spp. and Plasmodium spp.: A Review
Current Drug Targets Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders
Current Medicinal Chemistry Alternatives to Conventional Vaccines - Mediators of Innate Immunity
Current Drug Targets Microarray and Nanotechnology Applications of Functional Nanoparticles
Combinatorial Chemistry & High Throughput Screening Alternative Splice Variants of Survivin as Potential Targets in Cancer
Current Drug Discovery Technologies Treatment for Radiation-Induced Pulmonary Late Effects: Spoiled for Choice or Looking in the Wrong Direction?
Current Drug Targets Gene Therapy and Targeted Toxins for Glioma
Current Gene Therapy Targeting IGF-I, IGFBPs and IGF-I Receptor System in Cancer: The Current and Future in Breast Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Inhaled Antibiotics for Nosocomial Pneumonia
Inflammation & Allergy - Drug Targets (Discontinued) Anti-Respiratory Syncytial Virus Mechanism of <i>Houttuynia cordata</i> Thunb Exploration based on Network Pharmacology
Combinatorial Chemistry & High Throughput Screening Recent Advances in the Use of Cyclodextrins in Antifungal Formulations
Current Topics in Medicinal Chemistry Chemokines and their Receptors in Gut Homeostasis and Disease
Current Immunology Reviews (Discontinued)